References
Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–31. https://doi.org/10.1016/S1474-4422(12)70104-7.
Bian L, Zhang J, Wang M, Keep RF, Xi G, Hua Y. Intracerebral hemorrhage-induced brain injury in rats: the role of extracellular Peroxiredoxin 2. Transl Stroke Res. 2020;11(2):288–95. https://doi.org/10.1007/s12975-019-00714-x.
Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011;42(11):3067–74. https://doi.org/10.1161/STROKEAHA.111.617589.
Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019;18(5):428–38. https://doi.org/10.1016/S1474-4422(19)30069-9.
Wei C, Wang J, Foster LD, Yeatts SD, Moy C, Mocco J, Selim M; i-DEF Investigators. Effect of Deferoxamine on outcome according to baseline hematoma volume: a post hoc analysis of the i-DEF trial. Stroke. 2021 Nov. 18:STROKEAHA121035421. https://doi.org/10.1161/STROKEAHA.121.035421.
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. https://doi.org/10.1056/NEJMoa1214609.
Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–43. https://doi.org/10.1056/NEJMoa1603460.
European Stroke Initiative Writing C, Writing Committee for the EEC, Steiner T, Kaste M, Forsting M, Mendelow D, et al. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage the European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis. 2006;22(4):294–316. https://doi.org/10.1159/000094831.
Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60. https://doi.org/10.1161/STR.0000000000000069.
Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019;393(10175):1021–32. https://doi.org/10.1016/S0140-6736(19)30195-3.
Funding
YH, RFK, SK and GX were supported by grants NS-007222, NS-096917, NS106746, NS112394 and NS116786 from the National Institutes of Health (NIH). KGH was supported by a research fellowship grant from Neurosurgery Research & Education Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Not applicable
Conflict of interest
Fenghui Ye, Yingfeng Wan, Sravanthi Koduri, Katherine G. Holste, Richard F. Keep, Ya Hua and Guohua Xi declare that they have no conflict of interest.
Guohua Xi is Deputy Editor-in-Chief of Translational Stroke Research.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ye, F., Wan, Y., Koduri, S. et al. Too big, too small: selecting hematoma sizes for inclusion in intracerebral hemorrhage-deferoxamine trials. Transl. Stroke Res. 14, 281–282 (2023). https://doi.org/10.1007/s12975-022-01013-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-022-01013-8